Bio-rad Laboratories vs Fortrea Holdings
Bio-rad Laboratories and Fortrea Holdings are similar in size: $2.58bn and $2.72bn of revenue in their latest fiscal years. Fortrea Holdings grew faster (1.0% against 0.7%). Bio-rad Laboratories kept more of each dollar of sales as profit: a net margin of 29.4% against -36.2%.
| Latest fiscal year | Bio-rad LaboratoriesBIO, 2025 | Fortrea HoldingsFTRE, 2025 |
|---|---|---|
| Revenue | $2.58bn | $2.72bn |
| Revenue growth | 0.7% | 1.0% |
| Net income | $760m | −$986m |
| Operating margin | 1.8% | — |
| Net margin | 29.4% | -36.2% |
| Return on equity | 10.8% | -102.4% |
| Free cash flow | $375m | $88.3m |
| Cash | $530m | $175m |
| Total debt | $1.21bn | $1.07bn |
| Debt to equity | 16.2% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $296m | — |
| Employees | 7,450 | — |
| Market value | $10.02bn | $2.01bn |
| Price vs our value range | Above our value range | — |
| Moat score | 56 (Moderate) | — |
| Insider trades, 12 months | 0 buys, 2 sales | 0 buys, 24 sales |